A new investigational cancer vaccine developed by Merck & Co. and Moderna is customized based on the genome of each patient's ...
A WuXi AppTec director examines strategies for improving oral PROTAC exposure, from food-effect studies and linker design to ...
AbbVie's MAVYRET became the first of those antivirals cleared for acute infection in June 2025, with a 96% cure rate in trial ...
Medable’s Pamela Tenaerts says “the CRA still needs to be there,” as she and Tufts’ Ken Getz explain how agents change ...
The FDA has approved ViiV Healthcare’s Tivicay PD (dolutegravir) for treating HIV-1 in pediatric patients weighing at least 2 ...
FDA has logged more than 1,700 adverse event reports involving compounded semaglutide and tirzepatide as regulators, ...
Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation.
Earendil Labs and NewLimit round out the top three slots in the ranking below, which is limited to private biotechs that announced or disclosed financing between Jan. 1 and Aug. 12, 2026. Earendil ...
The U.S. entered August with more measles cases so far this year than it recorded during all of 2025. With kindergarten MMR coverage down to 92.5% from 95.2% before the pandemic, and Stanford modeling ...
Bristol Myers Squibb said Monday it will deploy an NVIDIA DGX SuperPOD, a prepackaged supercomputing platform that NVIDIA sells as a single standard unit, combining multiple compute racks, high-speed ...
The modern GLP-1 era effectively began with semaglutide’s 2017 approval as Ozempic. While the field had evolved considerably since the FDA approval of the first GLP-1 receptor agonist, exenatide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results